Get the Stockscreener App
2.52
0.00%
0.00
After Hours:
2.50
-0.02
-0.79%
Cibus Inc stock is traded at $2.52, with a volume of 97,536.
It is up +0.00% in the last 24 hours and down -15.44% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.52
Open:
$2.55
24h Volume:
97,536
Relative Volume:
0.59
Market Cap:
$77.60M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.125
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-1.18%
1M Performance:
-15.44%
6M Performance:
-69.00%
1Y Performance:
-85.39%
1-Day Range:
$2.45
$2.55
1-Week Range:
$2.34
$2.6377
52-Week Range:
$2.165
$23.18
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.52 | 77.60M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.16 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.07 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
657.97 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.25 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
119.94 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus director Prante Gerhard sells $2,898 in stock - MSN
Cibus director sells shares worth $2,817 - MSN
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Increases By 5.8% - MarketBeat
Cibus, Inc. (NASDAQ:CBUS) Sees Large Growth in Short Interest - Defense World
Cibus director Gerhard Prante sells $2,806 in stock - MSN
Cibus director Gerhard Prante sells $2,725 in stock - MSN
Cibus director Gerhard Prante sells $2,806 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,725 in stock By Investing.com - Investing.com UK
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer - GlobeNewswire Inc.
Cibus director Gerhard Prante sells $2,990 in stock - MSN
Cibus director Gerhard Prante sells $2,990 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $5,531 in stock - MSN
Cibus director Gerhard Prante sells $2,978 in stock By Investing.com - Investing.com Canada
Cibus director Gerhard Prante sells $2,978 in stock - MSN
Cibus director Gerhard Prante sells $5,531 in stock By Investing.com - Investing.com South Africa
Cibus’ Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits - CropLife
Cibus to Participate in the Sidoti Micro Cap Conference - The Manila Times
Cibus director Prante Gerhard sells $2,875 in stock By Investing.com - Investing.com Australia
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus Co-Founders to Present at Sidoti Micro Cap Conference: Spotlight on Gene Editing Innovation - StockTitan
Cibus (NASDAQ:CBUS) Given New $18.00 Price Target at Canaccord Genuity Group - MarketBeat
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Canaccord cuts Cibus stock target to $18, maintains buy rating By Investing.com - Investing.com UK
Cibus Raises $22.6M in Direct Offering, CEO Joins Investment Round at $2.50 Per Share - StockTitan
Cibus director Gerhard Prante sells shares worth $6,106 - MSN
Cibus director Gerhard Prante sells shares worth $6,106 By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,783 in stock By Investing.com - Investing.com Australia
Cibus' Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits - The Manila Times
Cibus director Gerhard Prante sells $2,783 in stock - Investing.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):